A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

CNBCJuly 11, 2026 at 12:00 PM

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

markets

Morgan Stanley upgrades Global Payments to Overweight on Worldpay optimism

Investing.comJuly 20, 2026 at 12:48 PM

markets

Inflation is broadening out, says Goldman economist

MarketWatchJuly 20, 2026 at 9:32 AM

markets

Is an opportunity to buy chip stocks nearing? These two big Wall Street banks are divided.

MarketWatchJuly 20, 2026 at 9:35 AM

← Back to all articles

Related Articles

Morgan Stanley upgrades Global Payments to Overweight on Worldpay optimism

Inflation is broadening out, says Goldman economist

Is an opportunity to buy chip stocks nearing? These two big Wall Street banks are divided.